Targeting Brain Inflammation to Treat Methamphetamine Addiction, Keith Heinzerling, MD | UCLAMDChat

UCLA addiction and internal medicine physician Keith Heinzerling, MD., medical director of the UCLA Center for Behavioral and Addiction Medicine, discusses new research aimed at reducing brain inflammation to improve brain function and reduce relapse in patients being treated for methamphetamine addiction.

View more webinar videos at http://uclahealth.org/uclamdchat